ClinicalTrials.Veeva

Menu

Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies (VANISH)

Natera logo

Natera

Status

Completed

Conditions

Trisomy 18
Trisomy 13
Trisomy 21
Vanishing Twin

Study type

Observational

Funder types

Industry

Identifiers

NCT05004337
21-050-NPT

Details and patient eligibility

About

The purpose of this study is to collect blood samples from women carrying a vanishing twin pregnancy to further develop Natera's non-invasive prenatal screening test to provide information about possible chromosomal conditions for the living twin

Enrollment

126 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women with either ultrasound-documented dizygotic (DZ) twin pregnancy or those whose Panorama Test™ results suggest increased risk for vanishing twin

Exclusion criteria

  • Monozygotic twin pregnancy
  • Non twin pregnancy
  • Maternal history of bone marrow or organ transplantation

Trial contacts and locations

21

Loading...

Central trial contact

Sophia Vourthis

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems